November 14, 2025
From super mice to super spice
Scientists reverse kidney damage in mice, hope for humans next
Mouse miracle sparks pet-test debate and bacon wars
TLDR: Researchers blocked ceramides and reversed acute kidney injury in mice, hinting at future human therapies but still preclinical. Comments explode with pet-testing jokes, skepticism over company ties, and diet-vs-drug debates, while hopefuls cheer early urine biomarkers as a potential lifesaver.
Scientists at University of Utah say they blocked a fatty molecule called ceramide and completely reversed acute kidney injury (dangerous short-term kidney failure) in mice. The mitochondria—the cell’s “power plants”—stayed pristine. It’s preclinical, but the lab is buzzing, and so is the internet. The community? Divided and loud. One camp is all-in on hope for ICU patients and heart surgery risks: “If urinary ceramides flag danger early, that’s a game-changer.” Another camp rolls eyes: “Mouse miracle, human meh.” Cue a wave of memes about “the powerhouse of the cell” and jokes that these are super mice with superhero kidneys. The spiciest thread: ethics and logistics. A cheeky commenter asks if this is a “terrific candidate for testing on pets first,” igniting debates over animal trials vs. fast-tracking humans. Then comes the Centaurus Therapeutics angle—since the senior author co-founded the company, skeptics sniff conflict-of-interest drama. Nutrition Twitter crashes the party, arguing whether diet can curb ceramides: “Cut bacon or cut the hype?” Meanwhile, optimists rally around the early-warning biomarker idea, imagining surgeons checking ceramide levels before procedures. The lab’s caution—“mice aren’t people”—doesn’t stop the crowd from dreaming, dunking, and arguing. Read the study in Cell Metabolism and the U of U notes here for receipts.
Key Points
- •Researchers at University of Utah Health identified ceramides as initiators of acute kidney injury by damaging mitochondria in kidney cells.
- •Ceramide levels rise rapidly after kidney injury in mice and human urine and correlate with injury severity, suggesting use as early biomarkers.
- •Genetic reduction of ceramide production created mice resistant to AKI under severe stress conditions.
- •A ceramide-lowering drug candidate from Centaurus Therapeutics prevented AKI and preserved kidney function and mitochondrial integrity in mice.
- •Findings are published in Cell Metabolism; the tested compound is preclinical and related to a human-trial drug, requiring further safety and efficacy research.